Assure Holdings Form S-1 Registration Statement Declared Effective
Assure Holdings Corp. (OTCQB: ARHH) announced that its resale registration statement on Form S-1 was declared effective by the SEC on February 12, 2021. This statement allows for the resale of shares by selling shareholders under a registration rights agreement from a December 2020 private placement. Assure has become a reporting issuer under the Exchange Act and will file reports available at www.sec.gov. The company specializes in intraoperative neuromonitoring services for surgeries and is recognized for high patient care standards.
- Resale registration statement on Form S-1 declared effective by SEC enhances liquidity.
- Becoming a reporting issuer under the Exchange Act increases transparency for investors.
- Recognition for high standards in patient care may bolster reputation and trust.
- Potential dilution of shares due to resale by selling shareholders.
DENVER, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH) announces that its resale registration statement on Form S-1 (the “Registration Statement”) filed under the U.S. Securities Act of 1933, as amended (the “Securities Act”), was declared effective by the Securities and Exchange Commission (“SEC”) on February 12, 2021. Assure filed the Registration Statement, to register the resale of shares of common stock, including shares issuable upon the exercise of warrants, by the selling shareholders named in the Registration Statement, under the terms of a registration rights agreement entered in connection with its December 2, 2020 private placement. For more information concerning the registration rights agreement and December 2, 2020 private placement, please refer to the Company’s news release dated December 2, 2020. Assure has become a reporting issuer under Section 15(d) of the Securities Exchange Act of 1934, as amended (“Exchange Act”), and will file reports under the Exchange Act with the SEC, which will be available at www.sec.gov.
Copies of the prospectus that is included in the Registration Statement may be obtained from Assure by request at Assure Holdings Corp., 4600 S. Ulster St, Suite 1225, Denver, Colorado 80237 or by email at Scott.Kozak@assureiom.com or by visiting https://www.sec.gov/Archives/edgar/data/1798270/000110465921022045/0001104659-21-022045-index.htm
This news release shall not constitute an offer to sell or the solicitation of an offer to buy any securities, nor shall there be any offer or sale of any securities, in any state or jurisdiction in which the offer, solicitation, or sale of securities would be unlawful. The securities being offered have not been approved or disapproved by the SEC or any Canadian securities commission, nor has any such regulatory authority passed upon the accuracy or adequacy of the Registration Statement.
About Assure Holdings
Assure Holdings Corp. is a Colorado-based company that works with neurosurgeons and orthopedic spine surgeons to provide a turnkey suite of services that support intraoperative neuromonitoring activities during invasive surgeries. Assure employs its own staff of technologists and uses its own state-of-the-art monitoring equipment, handles
Forward-Looking Statements
This news release may contain “forward-looking statements” within the meaning of applicable securities laws, including, but not limited to: the filing of the Registration Statement; information contained in the Registration Statement and the comments with respect to strategies, expectations, planned operations, and future actions of the Company. Forward-looking statements may generally be identified by the use of the words "anticipates," "expects," "intends," "plans," "should," "could," "would," "may," "will," "believes," "estimates," "potential," "target," or "continue" and variations or similar expressions. These statements are based upon the current expectations and beliefs of management and are subject to certain risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. These risks and uncertainties include, but are not limited to: sales by selling shareholders; the Registration Statement may be amended; the uncertainty surrounding the spread of COVID-19 and the impact it will have on the Company’s operations and economic activity in general; that the Company’s actions taken during the COVID-19 health crisis will be effective; and the risks and uncertainties discussed in the Registration Statement and our most recent annual and quarterly reports filed with the Canadian securities regulators and available on the Company’s profile on SEDAR at www.sedar.com, which risks and uncertainties are incorporated herein by reference. Readers are cautioned not to place undue reliance on forward-looking statements. Except as required by law, Assure does not intend, and undertakes no obligation, to update any forward-looking statements to reflect, in particular, new information or future events.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
Contact
Scott Kozak, Investor and Media Relations
Assure Holdings Corp.
1-720-287-3093
Scott.Kozak@assureiom.com
FAQ
What was announced in Assure Holdings Corp.'s press release on February 16, 2021?
What does the effective resale registration statement for ARHH imply for investors?
How can I access the reports filed by Assure Holdings Corp. with the SEC?
What services does Assure Holdings specialize in?
What impact does becoming a reporting issuer have for Assure Holdings Corp.?
